Get the Daily Brief
Latest Biotech News
mRNA Vaccine Funding Cuts Challenge Pandemic Preparedness
The U.S. Department of Health and Human Services (HHS) announced a $500 million cut in funding for mRNA vaccine development under BARDA, led by Health Secretary Robert F. Kennedy Jr. This move has...
10x Genomics Acquires Scale Biosciences to Expand Single-Cell Platform
10x Genomics has announced the acquisition of Scale Biosciences for $30 million upfront plus milestone payments, aiming to integrate Scale’s combinatorial barcoding and quantum barcoding...
Strand Therapeutics Raises $153M for Programmable mRNA Cancer Therapies
Strand Therapeutics secured $153 million in Series B funding to develop programmable mRNA therapeutics that stimulate immune recognition of resistant cancers by instructing tumor cells to produce...
FDA Updates and Regulatory Challenges in Rare Disease and Oncology
Recent regulatory developments include the FDA restricting use of bluebird bio's Skysona gene therapy due to increased cancer risk, denial of Stealth BioTherapeutics’ reconsideration request for...
Innovations in Cancer Immunotherapy and Targeted Treatments
Recent advances in cancer therapeutics highlight novel molecular targets and biotechnologies. Genmab and AbbVie’s T cell engager Epkinly showed positive Phase 3 results for follicular lymphoma....
Advances in Pediatric Radiology and Imaging Technologies
Pediatric imaging has seen significant progress, including automated 3D echocardiography software for right ventricular assessment, super-resolution fetal brain MRI, and improved abdominal...
Breakthroughs in Protein Engineering and Evolution in Biotechnology
Scientific teams at Scripps Research showcased the development of T7-ORACLE, a synthetic biology platform accelerating protein evolution thousands of times faster than natural processes. This...
Significant Biopharma Financing and Industry Investment Activity
Amid a shifting funding landscape, biopharma firms secured substantial financing rounds and pursued innovative capital strategies. Frazier Life Sciences closed a $1.3 billion fund to invest in...
Artificial Intelligence and Deep Learning Applied to Medical Diagnostics and Batteries
Artificial intelligence and deep learning technologies are advancing medical imaging and energy storage. New AI models improve pediatric MRI quality and automate anatomical measurements, while...
Eli Lilly’s Oral GLP-1 Pill Misses Weight Loss Targets
Eli Lilly disclosed mixed results for its oral GLP-1 receptor agonist orforglipron in a phase 3 obesity trial, delivering an 11.5% placebo-adjusted weight loss over 72 weeks—less than injectable...
10x Genomics Acquires Scale Biosciences to Expand Single-Cell Tech
10x Genomics announced the acquisition of Scale Biosciences for $30 million upfront plus milestone payments, aiming to augment its Chromium single-cell biology platform. Scale brings key...
HHS Cuts $500 Million in mRNA Vaccine Funding Amid Controversy
The U.S. Department of Health and Human Services, led by Secretary Robert F. Kennedy Jr., terminated nearly half a billion dollars in funding for mRNA vaccine research under BARDA. This move,...
Strand Therapeutics Raises $153M for Programmable mRNA Cancer Drugs
Strand Therapeutics secured $153 million in a Series B financing to advance its mRNA-based programmable therapeutics pipeline for oncology applications. The company’s lead candidate, STX-001,...
FDA Approves Boehringer’s Zongertinib for HER2-Mutated Lung Cancer
The FDA granted accelerated approval to Boehringer Ingelheim’s oral targeted therapy zongertinib for patients with non-small cell lung cancer harboring specific HER2 mutations. The approval...
Microglia Transplants Offer New Hope for Brain Disease Treatment
Researchers revealed a novel therapeutic strategy involving the transplantation of allogeneic microglia directly into the brain to address neurodegenerative and lysosomal storage diseases. This...
New AI Model Integrates CRISPR and Machine Learning for Macrophage Research
A team led by researchers at MedUni Vienna and the Austrian Academy of Sciences developed an innovative technique combining CRISPR gene editing and machine learning to dissect macrophage immune...
BioNTech Settles mRNA Patent Disputes with CureVac and GSK
BioNTech resolved ongoing patent litigation with CureVac and GSK by agreeing to pay $740 million plus royalties. The settlement clears regulatory hurdles and facilitates BioNTech’s $1.25 billion...
Eli Lilly’s Quarterly Earnings & Obesity Pipeline Highlights
Eli Lilly reported Q2 revenues ahead of expectations despite challenges in obesity drug competition. The company’s oral GLP-1 candidate underperformed versus injectable rivals, though the overall...
Advances in Pediatric Radiology Improve Diagnostic Accuracy
Multiple studies demonstrate significant progress in pediatric imaging, including automated 3D echocardiography for right ventricular assessment, diagnostic CT and MRI techniques, and...
FDA Moves on Gene Therapy and Transparency Practices
The Food and Drug Administration (FDA) is undergoing significant operational and decision-making changes affecting the biotech industry. Internally, employees have expressed concerns about...